Bioluminescent imaging was performed using a highly sensitive, IVIS Spectrum in vivo imaging system (PerkinElmer). D‐luciferin (Gold Biotechnology) was prepared per manufacturer's instructions in DPBS and filter sterilized with a 0.2 μm filter for a concentration of 15 mg/ml. For all in vivo imaging, D‐luciferin solution was intraperitoneally injected (150 mg/kg) in all mice for 10 min. Mice were then anesthetized with 2% isoflurane prior and during imaging with IVIS spectrum. Bioluminescence of D‐luciferin carried 4 T1‐Luc2‐RFP tumor cells was quantified using Living Image, in which regions of interest from displayed images were identified and quantified as the total flux which is the radiance (photons/sec) in each pixel summed or integrated over the ROI area.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.